Simvastatin reduces postischemic coronary dysfunction: Ultrastructural and functional findings after acute administration

Microvascular Research

Volumn 59, Issue 1, 2000, Pages 181-185

  Di Napoli, Pericle ^a   Di Muzio, Marcello ^a   Maggi, Alessandro ^a   Taccardi, Alfonso Antonio ^a   Conti, Pio ^b   Barsotti, Antonio ^a  

^a St Camillo s Hospital   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Coronary microcirculation; Endothelium; Reperfusion injury; Simvastatin

Indexed keywords

SIMVASTATIN;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ISCHEMIA; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ULTRASTRUCTURE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0033957011     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1999.2190     Document Type: Article

References (13)

1. Barsotti A., Di Napoli P., Di Girolamo E., Dini F. L., Gallina S., Modesti A. Role of myocardial edema on ischemia-reperfusion injury in isolated working rat hearts. FASEB J. 9:1995.
2. Di Napoli P., Barsotti A. Does 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition therapy exert a direct anti-ischemic effect. Circulation. 97:1998;937.
3. Di Napoli P., Contegiacomo G., Di Crecchio A., Di Muzio M., Tiloca P., Taccardi A. A., Maggi A., Barsotti A. Ischemic preconditioning of rat myocardium: Effects on postischemic coronary endothelium hyperpermeability and microcirculatory damage. J. Clin. Bas. Cardiol. 1:1998;37-42.
4. Frye R. L. Clinical reality of lowering total and LDL cholesterol. Circulation. 95:1997;306-307.
5. Goldstein J. L., Brown M. S. Regulation of the mevalonate pathway. Nature. 343:1990;425-430.
6. Kinoshita Y., Okamoto K., Yahata K., Yoshiota T., Sigimoto T. Clinical and pathological changes of the heart in the brain death maintained with vasopressin and epinephrine. Pathol. Res. Pract. 186:1990;173-179.
7. Kubes P., Granger N. D. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 31:1992;H611-H615.
8. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
9. 2+ responses in rat A10 vascular smooth muscle cells. Circ. Res. 74:1994;173-181.
10. Ramirez M. M., Quardt S. M., Kim D., Oshiro H., Minicozzi M., Duran W. N. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc. Res. 50:1995;223-234.
11. Satoh K., Ichihara K. Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischemic rat hearts. Eur. J. Pharmacol. 292:1995;271-275.
12. Vaughan C. J., Murphy M. B., Buckley B. M. Statins do more than just lower cholesterol. Lancet. 348:1996;1079-1082.
13. Ward B. J., Scoote M. Antioxidants attenuate postischemic endothelial cell swelling and luminal membrane blebbing in cardiac capillaries. Microvasc. Res. 53:1997;179-186.